NEWS & PUBLICATIONS

Oct 10

Next-Generation Anticoagulation Platform: Fast-Acting RNA Origami and DNA Reversal Agent Unveiled

In our latest publication, we introduce a cutting-edge, optimized RNA origami platform designed for anticoagulation therapy. Building on...

Oct 10

Revolutionizing Anticoagulant Therapy: RNA Origami’s Role in Safer, Reversible Blood Thinners

Helixomer is excited to share a breakthrough that could transform anticoagulant therapies and enhance patient care. Our research...

Oct 7

Helixomer: Pioneering RNA Origami to Revolutionize Safe and Effective Anticoagulation

Helixomer is pleased to announce the publication of our patent application, introducing the first-of-its-kind RNA origami aptamer...

May 11

Innovative RNA Origami Anticoagulant Research Highlighted at MSE100 Centennial Celebration

On Friday, April 5th, Thom LaBean showcased a poster titled "Multivalent, Aptamer-Decorated RNA Origami as Direct Thrombin Inhibitor with...